TFPI Monoklonaler Antikörper

TFPI Monoklonal Antikörper für WB, IF/ICC, Indirect ELISA

Wirt / Isotyp

Maus / IgG2a

Getestete Reaktivität

human

Anwendung

WB, IF/ICC, Indirect ELISA

Konjugation

Unkonjugiert

CloneNo.

1B12F11

Kat-Nr. : 66842-1-PBS

Synonyme

1B12F11, EPI, Extrinsic pathway inhibitor, LACI, Lipoprotein-associated coagulation inhibitor



Geprüfte Anwendungen

Produktinformation

66842-1-PBS bindet in WB, IF/ICC, Indirect ELISA TFPI und zeigt Reaktivität mit human

Getestete Reaktivität human
Wirt / Isotyp Maus / IgG2a
Klonalität Monoklonal
Typ Antikörper
Immunogen TFPI fusion protein Ag14980
Vollständiger Name tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)
Berechnetes Molekulargewicht251aa,29 kDa; 304aa,35 kDa
Beobachtetes Molekulargewicht 35-38 kDa
GenBank-ZugangsnummerBC015514
Gene symbol TFPI
Gene ID (NCBI) 7035
Konjugation Unkonjugiert
Form Liquid
Reinigungsmethode Protein-A-Reinigung
Lagerungspuffer PBS only
LagerungsbedingungenStore at -80°C. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

Tissue factor pathway inhibitor (TFPI) is a critical anticoagulant protein present in endothelium and platelets. TFPI is produced as two major isoforms in humans, TFPIa and TFPIb that result from alternative splicing. The TFPIb isoform localizes to the endothelium surface where it is a potent inhibitor of tissue factor-factor VIIa complexes that initiate blood coagulation. The TFPIa isoform is present in platelets. TFPI is a Kunitz-type serine protease inhibitor that exerts anticoagulant activity by blocking early procoagulant stimulia. TFPI can enhance anti-thrombotic treatment in sepsis, inflammatory diseases, and cardiovascular diseases.